News | CMDM Lab · National Taiwan University

2025

2025, Professor Yufeng Jane Tseng spoke at the invitation of Chang Gung University's College of Intelligence Computing and its Artificial Intelligence Research Center on "Artificial Intelligence in Drug Discovery and Drug Development: Applications and Prospects" [Chang Gung University]

Since September 2021 the lab has run GreenN (SAS), the Searching, Assessment and Screening System for Safer Alternative Chemicals, commissioned by the Chemicals Administration of the Ministry of Environment and ongoing [GreenN (SAS)]

2018, Professor Yufeng Jane Tseng spoke at the invitation of the Development Center for Biotechnology (DCB) on "The Impact of AI and Machine Learning on Clinical Data Science in Drug Development"
2018, Professor Yufeng Jane Tseng was invited to speak at the Healthcare Expo Taiwan (DCB X AI) on "AI for drug development: What's ready to go !"
2018, Professor Yufeng Jane Tseng was invited to speak at the symposium on high-throughput microchannel chemical synthesis on "Predictive Toxicology"
2018, the Development Center for Biotechnology (DCB) and Professor Yufeng Jane Tseng collaborated on machine learning methods for the ADMET properties of specific drug development programmes, with AI-driven virtual screening to refine lead selection and make lead discovery more efficient. [Global Bio & Investment]
2018, Stanford Medicine covered Professor Yufeng Jane Tseng's team and their drug for the negative symptoms and cognitive impairment of schizophrenia [Stanford Medicine]
2018, the drug for the negative symptoms and cognitive impairment of schizophrenia, from Professor Yufeng Jane Tseng's team, drew attention at the 2018 BioAsia and Bio SPARK SHOWCASE [TechNews] [photo]
2018, the Virtual Man team led by Professor Yufeng Jane Tseng was selected for the first cohort of the 2018 From IP to IPO programme and was invited to exhibit at the 2018 Taiwan Big Demo [photo 1] [photo 2]

2017, Professor Yufeng Jane Tseng's team was invited to the Ministry of Science and Technology's 2017 Future Tech Expo and received a Future Tech Breakthrough Award [NTU CSIE Announcement] [photo]
2017, a candidate protein drug for thrombosis, from the teams of Professor Tur-Fu Huang of the Graduate Institute of Pharmacology and Professor Yufeng Jane Tseng of the Graduate Institute of Biomedical Electronics and Bioinformatics, drew international attention [NTU Spotlight] [CNN health news] [LANDSCAPE]

2016, the RS-D7 research team led by Professor Yufeng Jane Tseng, across NTU, NCTU and the National Health Research Institutes, received the 13th National Innovation Award [NTU Spotlight]